Recall archive / FDA company announcement

Bryant Ranch Prepack Inc.: Morphine Sulfate 30 mg Extended-Release tablets — FDA announcement Jun 29, 2022

Reported terminated

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Jun 29, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product: Morphine Sulfate 30 mg Extended-Release tablets
Reason: Incorrect labeling
Classification: Not supplied
Recalling firm: Bryant Ranch Prepack Inc.
Quantity: Not supplied
Agency-reported status: Terminated in FDA listing
Source record identifier: 30ee6ca40e889363

Open the official record

Lot and product identifiers

Label field	Details supplied by the agency
Lot, code or applicability	06/28/2022 – Burbank, California, Bryant Ranch Prepack Inc. is voluntarily recalling one lot of Morphine Sulfate 30 mg Extended-Release tablets (Comprised of 10 bottles), and one lot of Morphine Sulfate 60 mg Extended-Release tablets (Comprised of 10 bottles) to the consumer level listed in the table below. The products have been found to have incorrect labeling where bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.; Product \| Strength \| Quantity per bottle \| NDC \| Lot \| Expiration; Morphine Sulfate Extended-Release Tablets \| 30 mg \| 100 \| 63629-1088-01 \| 179642 \| 11/30/2023; 60 mg \| 100 \| 63629-1089-01 \| 179643 \| 08/31/2023

Label field

Details supplied by the agency

Lot, code or applicability

06/28/2022 – Burbank, California, Bryant Ranch Prepack Inc. is voluntarily recalling one lot of Morphine Sulfate 30 mg Extended-Release tablets (Comprised of 10 bottles), and one lot of Morphine Sulfate 60 mg Extended-Release tablets (Comprised of 10 bottles) to the consumer level listed in the table below. The products have been found to have incorrect labeling where bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.; Product | Strength | Quantity per bottle | NDC | Lot | Expiration; Morphine Sulfate Extended-Release Tablets | 30 mg | 100 | 63629-1088-01 | 179642 | 11/30/2023; 60 mg | 100 | 63629-1089-01 | 179643 | 08/31/2023

Match all identifying details in the current notice. A brand name alone is not enough.

Product tables from the announcement

These identifying details come from the company announcement posted by FDA. Check the current notice for revisions.

FDA company announcement, table 1
Product	Strength	Quantity per bottle	NDC	Lot	Expiration
Morphine Sulfate Extended-Release Tablets	30 mg	100	63629-1088-01	179642	11/30/2023
Morphine Sulfate Extended-Release Tablets	60 mg	100	63629-1089-01	179643	08/31/2023

Announcement retrieved Oct 1, 2026. Official announcement.

Distribution

Not supplied

No US distribution state could be established from this record. Check the official notice.

Dates in the source

Fda listing date: Jun 29, 2022
Company announcement date: Jun 28, 2022

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.